Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20180129038549N8
IRCT20180129038549N8
Completed
Phase 3

Comparing the effect of intravenous midazolam and oral melatonin on controlling agitation caused by ketamine in emergency department

Esfahan University of Medical Sciences0 sites96 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
96
Status
Completed
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age over 18 years old
  • •Receiving ketamine as an anesthetic agent for small surgeries
  • •Patient's consent to participate in the study

Exclusion Criteria

  • •Obesity (BMI\>30\)
  • •Head trauma with loss of consciousness
  • •Brain tumor,
  • •Hydrocephaly
  • •Psychological disorders
  • •History of using Benzodiazepine during last two weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Clinical trial effect of midazolam and ondansetron on nausea and vomiting in parturient under cesarean with spinal anesthesianausea and vomiying in cesarean.Vomiting of pregnancy, unspecified
IRCT2016073027677N2rmia University of Medical Sciences126
Completed
Phase 2
effects of midazolam and ondansetron on nausea and vomiting after spinal anesthesia
IRCT2017021112251N4Vice Chancellor for research of Hamadan University of Medical Sciences80
Completed
Not Applicable
The comparative effect of intravenous midazolam and sufentanyl on shivering in cesarean deliveryShivering after spinal anesthesia.
IRCT201407191936N13Research Committee Bushehr University of Medical Sciences300
Completed
Not Applicable
Sedation and Duration of Spinal Anesthesia For Cesarean Section with IV Midazolam or DexmedetomidineAdverse effect of drug.Complication of surgical and medical care, unspecified
IRCT2016111410765N12Tabriz University of Medical Sciences70
Recruiting
Not Applicable
Comparison between Midazolam and Dexmedetomidine in bronchoscopyHealth Condition 1: null- All patients in the age group 18 to 65 years requiring flexible bronchoscopy in the Department of Respiratory Medicine.
CTRI/2017/10/009969Kasturba Medical College Manipal